Advanced Filter

Filter by Group

Filter by Market Availability

Did you mean aprd00160 of aprd00309?
Displaying all 2 drugs
Levodopa is a prodrug of dopamine that is administered to patients with Parkinson's due to its ability to cross the blood-brain barrier[Label]. Levodopa can be metabolised to dopamine on either side of the blood-brain barrier and so it is generally administered with a dopa decarboxylase inhibitor like carbidopa to prevent...
Approved
Matched Mixtures name: … LEVOCAENT OR 100/25/200 ... LEVOCAENT OR 100/25/200 ... LEVOCAENT OR 100/25/200 …
Carbidopa presents a chemical denomination of N-amino-alpha-methyl-3-hydroxy-L-tyrosine monohydrate. It potently inhibits aromatic amino acid decarboxylase (DDC) and due to its chemical properties, it does not cross the blood-brain barrier. Due to its activity, carbidopa is always administered concomitantly with levodopa. An individual formulation containing solely carbidopa was generated to treat...
Approved
Matched Mixtures name: … LEVOCAENT OR 100/25/200 ... LEVOCAENT OR 100/25/200 ... LEVOCAENT OR 100/25/200 …
Displaying all 2 drugs